EPFL, campus in Lausanne
Lausanne, Switzerland (GenevaLunch) – A group based mainly at EPFL in Lausanne have identified a molecule that may provide a stronger tool in the fight against excess weight and diabetes type 2, both of which are increasing at alarming rates worldwide, according to the journal Cell Metabolism.
Researchers Kristina Schoonjans, Johan Auwerx, Hiroyasu Yamamoto and Chikage Matakiand at EPFL, the Lausanne federal polytechnic university, working with Charles Thomas at EPFL and Roberto Pellicciari at the University of Perugia in Italy, say the selective molecule, called INT-777, can activate the TGR5 protein. TGR5 controls secretion of a hormone that has a critical role in pancreatic function and regulating blood sugar levels.
This work by genevalunch.com is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported.
News story, GenevaLunch, 7 September 2009.
Filed under: Health
Tags: blood sugar levels, Business, Charles Thomas, diabetes, Education, EPFL, excess weight, Hiroyasu Yamamoto Chikage Matakiand, INT-777, Johan Auwerx, Kristina Schoonjans, Lausanne, molecule, TGR5 protein